Dr. Suzanne Bruhn
Equibles does not estimate personal net worth.
Get an email with a short summary when Definium Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DFTX alertsAbout Dr. Suzanne Bruhn
Dr. Suzanne Bruhn is recorded as CEO at Definium Therapeutics, Inc. (DFTX). The newest filing on record that lists Dr. Suzanne Bruhn as CEO at Definium Therapeutics, Inc. (DFTX) is dated April 27, 2026. Definium Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Definium Therapeutics, Inc. includes Dr. Roger Crystal (CEO), JR Rahn (CEO), Robert Barrow (CEO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 27, 2026
-
2022-01-01–2025-04-23
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Definium Therapeutics, Inc.
- Dr. Roger Crystal CEO
- JR Rahn CEO
- Robert Barrow CEO
- Stephen Hurst CEO
- Carol A. Vallone Chairman
- Brandi L. Roberts CFO
- David Gryska CFO
- Roger Adsett COO, Board Member
- Carrie F. Liao Chief Accounting Officer
- Andreas Krebs Board Member
Recent activity
No call appearances or filed executive changes recorded yet.